<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Middle East Afr J Ophthalmol</journal-id>
      <journal-id journal-id-type="publisher-id">MEAJO</journal-id>
      <journal-title-group>
        <journal-title>Middle East African Journal of Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0974-9233</issn>
      <issn pub-type="epub">0975-1599</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23580859</article-id>
      <article-id pub-id-type="pmc">3617536</article-id>
      <article-id pub-id-type="publisher-id">MEAJO-20-83</article-id>
      <article-id pub-id-type="doi">10.4103/0974-9233.106400</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transient Increased Exudation after Photodynamic Therapy of Intraocular Tumors</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mashayekhi</surname>
            <given-names>Arman</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shields</surname>
            <given-names>Carol L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shields</surname>
            <given-names>Jerry A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, USA</aff>
      <author-notes>
        <corresp id="cor1"><bold>Corresponding Author:</bold> Dr. Arman Mashayekhi, Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA. E-mail: <email xlink:href="arman_mash@yahoo.com">arman_mash@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2013</year>
      </pub-date>
      <volume>20</volume>
      <issue>1</issue>
      <fpage>83</fpage>
      <lpage>86</lpage>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Middle East African Journal of Ophthalmology</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>To report transient increased exudation after photodynamic therapy (PDT) of three different intraocular tumors (retinal hemangioblastoma, retinal astrocytoma, amelanotic choroidal melanoma). PDT with verteporfin (6 mg/m<sup>2</sup> body surface area) was delivered at a dose of 50 J/cm<sup>2</sup> and intensity of 600 mW/cm<sup>2</sup> over 83 s. All patients experienced decreased vision within a few days following PDT. Optical coherence tomography showed development of subfoveal fluid in all cases and noncystoid intraretinal edema in the eye with juxtapapillary retinal hemangioblastoma. There was complete absorption of retinal/subretinal fluid with improvement of visual acuity to 20/20 in all cases between 3 weeks to 4 months after PDT.</p>
      </abstract>
      <kwd-group>
        <kwd>Astrocytoma</kwd>
        <kwd>Choroidal Melanoma</kwd>
        <kwd>Complication</kwd>
        <kwd>Exudation</kwd>
        <kwd>Eye</kwd>
        <kwd>Photodynamic Therapy</kwd>
        <kwd>Retinal Hemangioblastoma</kwd>
        <kwd>Serous Retinal Detachment</kwd>
        <kwd>Tumor</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>INTRODUCTION</title>
      <p>Photodynamic therapy (PDT) is based on the interaction of light with a photosensitizer leading to release of cytotoxic singlet oxygen and resultant oxidative damage to the target tissue.<xref ref-type="bibr" rid="ref1">1</xref> The tumoricidal activity of PDT is caused by direct cell damage and microvascular injury.<xref ref-type="bibr" rid="ref2">2</xref>&#x2013;<xref ref-type="bibr" rid="ref4">4</xref> PDT has been used for the management of various intraocular tumors including circumscribed<xref ref-type="bibr" rid="ref5">5</xref>&#x2013;<xref ref-type="bibr" rid="ref8">8</xref> and diffuse choroidal hemangioma,<xref ref-type="bibr" rid="ref5">5</xref>&#x2013;<xref ref-type="bibr" rid="ref9">9</xref> choroidal melanoma,<xref ref-type="bibr" rid="ref10">10</xref>&#x2013;<xref ref-type="bibr" rid="ref12">12</xref> retinal hemangioblastoma,<xref ref-type="bibr" rid="ref13">13</xref>&#x2013;<xref ref-type="bibr" rid="ref16">16</xref> retinal vasoproliferative tumor,<xref ref-type="bibr" rid="ref17">17</xref><xref ref-type="bibr" rid="ref18">18</xref> and retinal astrocytoma.<xref ref-type="bibr" rid="ref19">19</xref>&#x2013;<xref ref-type="bibr" rid="ref21">21</xref> We describe the development of transient tumor vascular hyperpermeability with increased intraretinal/subretinal fluid following PDT of three different types of intraocular tumors (retinal hemangioblastoma, retinal astrocytoma, amelanotic choroidal melanoma). </p>
      <p>Approval was obtained from institutional review board of Wills Eye Institute. Written informed consent was obtained from patients.</p>
    </sec>
    <sec id="sec1-2">
      <title>CASE REPORTS</title>
      <sec id="sec2-1">
        <title>Case 1</title>
        <p>An asymptomatic 61-year-old female with a 1.5 mm juxtapapillary retinal hemangioblastoma OD showed progressive retinal edema despite three prior off-label intravitreal bevacizumab injections (1.5 mg) [Figures <xref ref-type="fig" rid="F1">1a</xref> and <xref ref-type="fig" rid="F1">b</xref>]. PDT was delivered to the tumor, followed immediately by a fourth intravitreal bevacizumab injection (1.5 mg). One day after the procedure, the patient presented with a complaint of blurred vision. On examination, the best corrected visual acuity (BCVA) had decreased from 20/20 preoperatively to 20/70. Optical coherence tomography (OCT) showed extension of retinal edema into fovea [<xref ref-type="fig" rid="F1">Figure 1c</xref>]. There was spontaneous recovery of BCVA to 20/25 and complete resolution of macular edema 3 weeks after PDT [<xref ref-type="fig" rid="F1">Figure 1d</xref>]. Eight months after PDT BCVA was 20/20 but the patient complained of a persistent paracentral ring of haziness. The tumor remained stable with no recurrent intra- or subretinal fluid during subsequent follow-up of 3 years.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>(a) Juxtapapillary retinal hemangioblastoma with adjacent lipid exudation. Note minimal lipid exudation in the papillomacular bundle region (b) Foveal contour is normal before photodynamic theraphy (PDT) (c) OCT performed 1 day after PDT shows retinal edema and subretinal fluid under the foveola (d) Three weeks after PDT there is complete reabsorption of intraretinal and subretinal fluid. There are a few focal intraretinal optically dense juxtafoveal deposits consistent with ophthalmoscopically visible lipid exudates</p>
          </caption>
          <graphic xlink:href="MEAJO-20-83-g001"/>
        </fig>
      </sec>
      <sec id="sec2-2">
        <title>Case 2</title>
        <p>A 17-year-old female with juxtafoveal retinal astrocytoma OD measuring 6 mm in diameter and 3 mm in thickness underwent successful standard fluence PDT with verteporfin (6 mg/m<sup>2</sup>; 689 nm diode laser; 600 mW/cm<sup>2</sup>; 83 s) for management of macular edema originating from the retinal tumor with improvement in BCVA from 20/70 to 20/30. Three years after PDT, BCVA decreased to 20/60 due to recurrent macular edema [Figures <xref ref-type="fig" rid="F2">2a</xref> and <xref ref-type="fig" rid="F2">b</xref>] and she underwent a second standard fluence PDT with verteporfin. Two days after the second PDT, she noted decreased vision. On examination, the BCVA was 20/80 and OCT showed increased subretinal fluid at the fovea [<xref ref-type="fig" rid="F2">Figure 2c</xref>]. Three weeks later BCVA improved to 20/60 and 4 months later best corrected visual acuity was 20/20 with complete resolution of macular edema and subfoveal fluid [<xref ref-type="fig" rid="F2">Figure 2d</xref>]. The patient required two more sessions of PDT during the subsequent 3 years for management of recurrent macular edema.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>(a) Partially pigmented retinal astrocytoma (needle biopsy proven) with lipid exudation at the superior, inferior, and nasal margins extending into the fovea, forming a foveal star (b) OCT before PDT reveals moderate intraretinal cystoid edema at the fovea (c) Three days after PDT there is increased subretinal fluid (d) Four months later, there is complete reabsorption of intraretinal and subretinal fluid leaving retinal atrophy</p>
          </caption>
          <graphic xlink:href="MEAJO-20-83-g002"/>
        </fig>
      </sec>
      <sec id="sec2-3">
        <title>Case 3</title>
        <p>A 62-year-old female with visual acuity of 20/20 and an enlarging amelanotic choroidal melanoma in her left eye (OS) measuring 7 mm in basal dimension and 2.7 mm in thickness [Figures <xref ref-type="fig" rid="F3">3a</xref> and <xref ref-type="fig" rid="F3">b</xref>] was treated with PDT. Two days after PDT, the patient noted decreased vision OS and 11 days later, the best corrected visual acuity was measured at 20/200. OCT confirmed subretinal fluid extending from the treated melanoma into the foveal region [<xref ref-type="fig" rid="F3">Figure 3c</xref>]. The vision improved without treatment 1 month after PDTand 3 months later there was complete resolution of subretinal fluid with visual acuity of 20/20 [<xref ref-type="fig" rid="F3">Figure 3d</xref>]. Subsequent tumor growth required treatment with I-125 plaque radiation.</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p>(a) Color fundus photograph showing small amelanotic choroidal melanoma with documented growth (b) OCT shows normal fovea before PDT (c) Eleven days after PDT, neurosensory retinal detachment extending under the fovea is evident (d) Three months after PDT, subretinal fluid has completely disappeared and foveal contour has returned to normal</p>
          </caption>
          <graphic xlink:href="MEAJO-20-83-g003"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>DISCUSSION</title>
      <p>Increased exudation has been reported following PDT of ocular conditions other than tumors, including choroidal neovascular membrane (CNVM) and polypoidal choroidal vasculopathy.<xref ref-type="bibr" rid="ref22">22</xref>&#x2013;<xref ref-type="bibr" rid="ref25">25</xref> Reports of increased leakage after PDT from intraocular tumors are limited to juxtapapillary retinal hemangioblastoma.<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref16">16</xref> Possible mechanisms of post-PDT vascular hyper-permeability include direct damage to endothelial cells,<xref ref-type="bibr" rid="ref26">26</xref> retinal pigment epithelial damage and dysfunction,<xref ref-type="bibr" rid="ref27">27</xref><xref ref-type="bibr" rid="ref28">28</xref> or an angiogenic response induced by PDT.<xref ref-type="bibr" rid="ref29">29</xref><xref ref-type="bibr" rid="ref30">30</xref>
</p>
      <p>A post-PDT increase in intraocular tumor leakage is an early phenomenon causing symptoms within a few days of PDT. In all three of our cases, the visual disturbance was transient with complete absorption of fluid and recovery of vision to pre-PDT levels within 1 month after PDT. Despite the transient nature of increased leakage post-PDT, prolonged presence of intraretinal or subretinal fluid or deposition of lipid exudate at the fovea could potentially lead to permanent structural damage and loss of vision. An example is the patient in Case 1 above who noted persistent paracentral field defects up to 8 months after complete absorption of fluid.</p>
      <p>The use of off-label intravitreal bevacizumab injection immediately after PDT in our first case did not prevent development of increased retinal edema. It has been shown that increased vascular leakage starts as early as 5-10 min after PDT of rat cremaster muscle.<xref ref-type="bibr" rid="ref3">3</xref> Additionally some have proposed that application of anti-VEGF compounds before PDT may be more effective in blocking the effects of VEGF.<xref ref-type="bibr" rid="ref30">30</xref> Fingar and co-workers<xref ref-type="bibr" rid="ref3">3</xref> also found a direct relationship between dose of photosensitive material used (Photofrin; Pinnacle Biologics Inc., Bannockburn, IL, USA) and the severity of increased vascular leakage and were able to block post-PDT leakage by intra-arterial injection of indomethacin.</p>
      <p>In summary, we report development of transient increased leakage causing increased retinal edema or subretinal fluid following PDT for different types of intraocular tumors (retinal hemangioblastoma, retinal astrocytoma, amelanotic choroidal melanoma). Further studies are needed to identify effective methods for prevention of this potentially vision-threatening complication.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Support provided by a donation from Michael, Bruce, and Ellen Ratner, New York, NY 20 (JAS, CLS), the Paul Kayser International Award of Merit in Retina Research, Houston TX (JAS), Mellon Charitable Giving from the Martha W. Rogers Charitable Trust, Philadelphia, PA (CLS) and the Eye Tumor Research Foundation, Philadelphia, PA (CLS, JAS)</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oleinick</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>The photobiology of photodynamic therapy: Cellular targets and mechanisms</article-title>
          <source>Radiat Res</source>
          <year>1998</year>
          <volume>150</volume>
          <fpage>S146</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">9806617</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henderson</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Fingar</surname>
              <given-names>VH</given-names>
            </name>
          </person-group>
          <article-title>Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model</article-title>
          <source>Photochem Photobiol</source>
          <year>1989</year>
          <volume>49</volume>
          <fpage>299</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">2525260</pub-id>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fingar</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Wieman</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Wiehle</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Cerrito</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability, and leukocyte adhesion</article-title>
          <source>Cancer Res</source>
          <year>1992</year>
          <volume>52</volume>
          <fpage>4914</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">1387584</pub-id>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fingar</surname>
              <given-names>VH</given-names>
            </name>
          </person-group>
          <article-title>Vascular effects of photodynamic therapy</article-title>
          <source>J Clin Laser Med Surg</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>323</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9612199</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt-Erfurth</surname>
              <given-names>UM</given-names>
            </name>
            <name>
              <surname>Michels</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kusserow</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jurklies</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Augustin</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy for symptomatic choroidal hemangioma: Visual and anatomic results</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>2284</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">12466172</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Landau</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Steen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Seregard</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy for circumscribed choroidal haemangioma</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2002</year>
          <volume>80</volume>
          <fpage>531</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">12390166</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Kaiser</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Sears</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rundle</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Rennie</surname>
              <given-names>IG</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy of circumscribed choroidal haemangioma</article-title>
          <source>Br J Ophthalmol</source>
          <year>2004</year>
          <volume>88</volume>
          <fpage>1414</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">15489484</pub-id>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boixadera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Arum&#xED;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez-Castillo</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Encinas</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Elizalde</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Blanco-Mateos</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma</article-title>
          <source>Ophthalmology</source>
          <year>2009</year>
          <volume>116</volume>
          <fpage>100</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">18973950</pub-id>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huiskamp</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>M&#xFC;skens</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Ballast</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hooymans</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Diffuse choroidal haemangioma in sturge-weber syndrome treated with photodynamic therapy under general anaesthesia</article-title>
          <source>Graefes Arch Clin Exp Ophthalmol</source>
          <year>2005</year>
          <volume>243</volume>
          <fpage>727</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">15702328</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez</surname>
              <given-names>VH</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Theodossiadis</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Flotte</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Gragoudas</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy of pigmented choroidal melanomas</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>1995</year>
          <volume>36</volume>
          <fpage>871</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">7706035</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barbazetto</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Rollins</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abramson</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Treatment of choroidal melanoma using photodynamic therapy</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>135</volume>
          <fpage>898</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12788137</pub-id>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donaldson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Mackenzie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>G W</given-names>
            </name>
          </person-group>
          <article-title>Primary treatment of choroidal amelanotic melanoma with photodynamic therapy</article-title>
          <source>Clin Experiment Ophthalmol</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>548</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16181294</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt-Erfurth</surname>
              <given-names>UM</given-names>
            </name>
            <name>
              <surname>Kusserow</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Barbazetto</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Laqua</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Benefits and complications of photodynamic therapy of papillary capillary hemangiomas</article-title>
          <source>Ophthalmology</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>1256</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">12093647</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aaberg</surname>
              <given-names>TM</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Aaberg</surname>
              <given-names>TM</given-names>
              <suffix>Sr</suffix>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Gilman</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Myles</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy</article-title>
          <source>Arch Ophthalmol</source>
          <year>2005</year>
          <volume>123</volume>
          <fpage>328</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">15767474</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziemssen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Voelker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Inhoffen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bartz-Schmidt</surname>
              <given-names>KU</given-names>
            </name>
            <name>
              <surname>Gelisken</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy</article-title>
          <source>Eye (Lond)</source>
          <year>2007</year>
          <volume>21</volume>
          <fpage>1125</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">17545966</pub-id>
        </element-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mennel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Callizo</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma</article-title>
          <source>Acta Ophthalmol</source>
          <year>2009</year>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blasi</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Scupola</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tiberti</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Sasso</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Balestrazzi</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy for vasoproliferative retinal tumors</article-title>
          <source>Retina</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>404</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16603958</pub-id>
        </element-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saldanha</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Edrich</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Treatment of vasoproliferative tumors with photodynamic therapy</article-title>
          <source>Ophthalmic Surg Lasers Imaging</source>
          <year>2008</year>
          <volume>39</volume>
          <fpage>143</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">18435340</pub-id>
        </element-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mennel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hausmann</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy for exudative hamartoma in tuberous sclerosis</article-title>
          <source>Arch Ophthalmol</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>597</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16606894</pub-id>
        </element-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shields</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Materin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Marr</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Krepostman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shields</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy</article-title>
          <source>Arch Ophthalmol</source>
          <year>2008</year>
          <volume>126</volume>
          <fpage>273</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">18268226</pub-id>
        </element-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eskelin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tommila</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Palosaari</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kivel&#xE4;</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas</article-title>
          <source>Acta Ophthalmol</source>
          <year>2008</year>
          <volume>86</volume>
          <fpage>794</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">18759802</pub-id>
        </element-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Holz</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Linares</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mieler</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
          <article-title>Exudative complications after photodynamic therapy</article-title>
          <source>Arch Ophthalmol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>1649</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">14609931</pub-id>
        </element-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mennel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Eggarter</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy</article-title>
          <source>Am J Ophthalmol</source>
          <year>2005</year>
          <volume>140</volume>
          <fpage>758</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">16226542</pub-id>
        </element-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jalil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mercieca</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chaudhry</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Stanga</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Choroidal nonperfusion with significant subretinal exudation after PDT of predominantly classic CNV: An OCT and FFA study</article-title>
          <source>Eur J Ophthalmol</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>490</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">19396803</pub-id>
        </element-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tobita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohno-Matsui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mochizuki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Transient serous retinal detachment after photodynamic therapy for polypoidal choroidal vasculopathy</article-title>
          <source>Jpn J Ophthalmol</source>
          <year>2008</year>
          <volume>52</volume>
          <fpage>518</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">19089583</pub-id>
        </element-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt-Erfurth</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Laqua</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schl&#xF6;tzer-Schrehard</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Viestenz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Naumann</surname>
              <given-names>GO</given-names>
            </name>
          </person-group>
          <article-title>Histopathological changes following photodynamic therapy in human eyes</article-title>
          <source>Arch Ophthalmol</source>
          <year>2002</year>
          <volume>120</volume>
          <fpage>835</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">12049594</pub-id>
        </element-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt-Erfurth</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hasan</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gragoudas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Michaud</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Flotte</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Birngruber</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Vascular targeting in photodynamic occlusion of subretinal vessels</article-title>
          <source>Ophthalmology</source>
          <year>1994</year>
          <volume>101</volume>
          <fpage>1953</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">7997334</pub-id>
        </element-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schnurrbusch</surname>
              <given-names>UE</given-names>
            </name>
            <name>
              <surname>Welt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Wiedemann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy</article-title>
          <source>Br J Ophthalmol</source>
          <year>2001</year>
          <volume>85</volume>
          <fpage>1086</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">11520762</pub-id>
        </element-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrario</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gomer</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Avastin enhances photodynamic therapy treatment of Kaposi&#x2019;s sarcoma in a mouse tumor model</article-title>
          <source>J Environ Pathol Toxicol Oncol</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>251</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16566722</pub-id>
        </element-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt-Erfurth</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schl&#xF6;tzer-Schrehard</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Cursiefen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Michels</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Beckendorf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Naumann</surname>
              <given-names>GO</given-names>
            </name>
          </person-group>
          <article-title>Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>4473</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">14507895</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
